Author(s): Sorri I, Herrgrd E, Viinikainen K, Pkknen A, Heinonen S,
Abstract Share this page
Abstract Vigabatrin (VGB) is an important treatment option for infantile spasms. Vigabatrin-induced visual field defects are at present the most important safety issue in the use of the drug. The knowledge concerning VGB-associated visual dysfunction in pediatric patients, particularly in those who have been exposed to VGB in utero is limited. We explored ophthalmic and neurologic findings in two children who have been exposed prenatally to VGB.
This article was published in Epilepsy Res
and referenced in Journal of Addiction Research & Therapy